Mechanistically, lactate emitted by glycolytic breast cancer cells induced HISLA upregulation in TAMs via ERK-ELK2 signaling, which was then released in the tumor microenvironment in extracellular vesicles and taken up by tumor cells. The gene discussed is HISLA; the disease is neoplasm.